Open AccessEnsartinib as Treatment for ALK-Rearranged NSCLC
Author(s) -
Selina K. Wong,
Amanda S. Cass,
L. Horn
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000721308.30680.3f
Subject(s) - crizotinib , lung cancer , anaplastic lymphoma kinase , medicine , oncology , alk inhibitor , chemotherapy , cancer , population , cancer research , malignant pleural effusion , environmental health